425: Strive, Semler Scientific Merger Communication

Strive, Inc. has filed a communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• A communication was reposted on X.com by Matthew Cole, Chief Executive Officer of Strive, Inc., on November 18, 2025.
• The communication is in connection with Strive's proposed business combination with Semler Scientific, Inc.
• It includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties related to the transaction.
• Strive has filed a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.
• Strive, Semler Scientific, and certain of their directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication clarifies that it does not constitute an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is neutral, primarily serving as a procedural communication about a proposed merger and a comprehensive disclosure of associated risks and forward-looking statement caveats. It doesn't present overwhelmingly positive or negative news, but rather necessary legal disclosures.

Positives

• The proposed business combination is expected to yield strategic and financial benefits for the combined company.
• Anticipated positive impact on the combined company's future financial performance.
• Expected realization of cost savings and strategic gains from the merger.

Negatives

• The proposed transaction may not close when expected or at all due to unfulfilled conditions.
• Anticipated benefits, cost savings, and strategic gains may not be realized as expected.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The transaction may be more expensive or take longer to complete than initially projected.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business or employee relationships could arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all, potentially due to changes in Bitcoin treasury strategies, risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The filing discusses the outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including anticipated strategic and financial benefits, the expected impact on the combined company's future financial performance, and the timing of the closing. However, it heavily caveats these with inherent risks and uncertainties, stating that actual results could differ materially from any projected future results.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., reposted this communication on X.com on November 18, 2025.
• Each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations.

Industry Context

NA

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's share issuance; requirement for Semler Scientific stockholders to approve the transaction; potential changes in share price for both companies.
• Customers: Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Employees: Potential changes to employee relationships resulting from the announcement or completion of the proposed transaction.

Next Steps

• Strive and Semler Scientific will continue to work towards the closing of the proposed transaction.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Investment, Bitcoin Treasury, Digital Assets